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Relationship Between Body Mass Index and Severity of Coronary Artery Disease
Mohamed Abdel Ghany
Cardiology Department- Assuit University, Assuit, Egypt
Background: Obesity is a major risk factor for diabetes, hypertension and coronary
artery disease (CAD). Relation between BMI and severity of CAD is matter of
controversy. Our aim was to study relation between obesity assessed with BMI and
severity of CAD assessed with invasive coronary angiography (ICA).
Methods: 415 consecutive patients who underwent (ICA) for different indications
included in the study. Coronary stenosis > 50 or more considered signiﬁcant. Severity
of CAD was classiﬁed into single, two and three vessels disease. Left main affection
was classiﬁed as separate category. BMI was calculated and patients classiﬁed as
Normal (BMI 20-24.9 kg/m2), overweight (BMI 25-29.9 kg/m2) and obese (BMI >
30 kg/m2). Findings of ICA compared with classes of BMI.
Results: The mean BMI was 31.2  4.8 kg/m2. Clinical characteristics and ICA
results are shown in table 1. The mean number of diseased vessels was 1.45 in all BMI
classes (p ¼ 0.73). Multivariate analysis revealed no signiﬁcant association between
BMI and severity of CAD. Table 2
Conclusion: BMI was not related to severity of CAD. Lager studies are needed to
conﬁrm our results.
Table 1. Patients’ clinical characteristics and ICA results.Normal weight
N ¼ 89Over weight
N ¼ 121Obese
N¼ 205 P valueAge
Mean  SD65  8.3 58  9.1 55  10.2 NSMALE 58 (73%) 85 (70.3 %) 144(70.2%) NSSMOKERS 28 (31.5 %) 37 (30.5%) 81(39.5%) NSHYPERTENSION 43 (48.3%) 78 (64.4%) 154 (75.2%) 0.000DM 15 (16.8%) 25 (20.6%) 62 (30 %) 0.001DYSLIPDEMIA 41 (46%) 56 (46.3%) 155 (75.6 %) 0.0013 VESSEL DISEASE 22 (24.7 %) 25 (20.6 %) 48 (23.4%) 0.75LEFT MAIN DISEASE 4 (4.4%) 5 (4.1%) 11 (5.3%) 0.92Table 2. Multivariate analysis for risk of 3 vessels and left main disease.3 VESSELS DISEASE LEFT MAIN DISEASEODDS RATIO 95 % CI P VALUE ODDS RATIO 95 % CI P VALUEOver WEIGHT 1.23 0.65- 2.2 0.75 0.84 0.25-3.28 0.65Obese 1.12 0.65-2.0 0.82 1.01 0.34-3.65 0.72Hypertension 0.94 0.52-1.62 0.001 1.05 0.32-1.45 0.6DM 3.1 1.9-5.7 0.000 1.03 0.35-2.88 0.83Dyslipidemia 1.1 0.98- 2.86 0.002 0.67 0.74-2.92 0.74CRT-151
Coronary Artery Calcium Score as a Predictor of Major Adverse Cardiovascular Events
Following Revascularization
Michael Donovan,1 Rolf Graning,1 Bradley Serwer,2 Anjeanette Benjamin,1
Scott Hopkins,1 John Thurber,1 Michael Ferguson1
1Walter Reed National Military Medical Center, Bethesda, MD; 2Fort Belvoir
Community Hospital, Fort Belvoir, VA
Background: A quantitative association between pre-procedural coronary artery cal-
cium (CAC) and revascularization outcomes has yet to be described. The objective of
this study was to determine the association between pre-procedural CAC and majoradverse cardiovascular events (MACE) after patients have undergone revascularization
via percutaneous coronary intervention (PCI) or coronary artery bypass grafting
(CABG).
Methods: Seventy-three patients were enrolled in a retrospective cohort who un-
derwent CAC scoring via Electron Beam or Multi-detector Computerized Tomog-
raphy prior to surgical or percutaneous revascularization. CAC scoring was computed
using Agatston’s method. MACE was deﬁned as cardiovascular death, myocardial
infarction or target vessel revascularization (TVR). Medians were compared using the
Mann-Whitney test with signiﬁcance deﬁned at p<0.05. Odds ratios (OR) and 95%
conﬁdence intervals (CI) were calculated for TVR using Fisher’s exact method.
Multivariate analysis was performed to identify independent associations for MACE.
Follow-up was obtained via our electronic health record.
Results: 745 PCI’s and 279 CABG’s were reviewed over a six year period from 2005-
2010. 38 PCI and 35 CABG patients met inclusion criteria. For the PCI cohort, 54
vessels were stented, median age was 60 years, median follow-up was 37 months and 8
patients suffered MACE. The median CAC score was 622 for those who experienced
MACE versus 188 without MACE (p¼0.03). For the CABG cohort, 95 vessels were
grafted, median age was 64 years, median follow-up was 30 months and 6 patients
suffered MACE. The median CAC score was 1524 for those who experienced
MACE versus 434 without MACE (p¼0.01). Patients with a CAC score > 400 were
more likely to undergo TVR after PCI (OR¼6.0, 95% CI 1.02-35.34, p¼0.04), but
not CABG (OR¼2.14, 95% CI 0.33-13.58, p¼0.65). CAC scores were not inde-
pendently associated with MACE for either CABG or PCI patients on a multivariate
analysis including CAC, age, hypertension, diabetes mellitus, hyperlipidemia, stent
diameter, or stent length.
Conclusions: This data supports the association of elevated CAC scores and MACE
following revascularization in both PCI and surgical patients. Elevated CAC scores >
400 were associated with TVR in the PCI group, but not in the CABG group.
Increased CAC score was not found to be an independent predictor of MACE.
Further investigation with a larger study population is warranted to determine inde-
pendent predictors of MACE following revascularization in patients with elevated
CAC scores.
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Predictors of Recurrent Chest Pain in Patients with Vasospastic Angina Based on
3-year Clinical Outcomes
Seung-Woon Rha,1 Byoung Geol Choi,1 Se Yeon Choi,1 Sang-Ho Park,2 Ji Young Park,3
Woong Gil Choi,4 Yun-Hyeong Cho,5 Won-Yu Kang,6 Dong Joo Oh2
1Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of;
2Cardiology Department, Soonchunhyang University Cheonan Hospital, Cheonan, Korea,
Republic of; 3Cardiovascular Center, Eulji University, Eulji General Hospital, Seoul,
Korea, Republic of; 4Cardiology, Chungju Kunkuk University, Chungju, Korea, Republic
of; 5Cardiovascular Center, Myongji Hospital, Seoul, Korea, Republic of; 6Cardiovascular
Center, Kwanju Bohoon General Hospital, Kwangju, Korea, Republic of
Background: Coronary artery spasm (CAS) is a major cause of myocardial ischemia.
However, long-term clinical outcomes of CAS are largely unknown. We investigated
predictors of recurrent chest pain in patients (pts) with vasospastic angina based on
3-year clinical outcomes.
Methods: A total of 2,797 consecutive pts without signiﬁcant coronary artery disease
who underwent Acetylcholine (Ach) test were enrolled between Nov 2004 and Oct
2010.
Results: Ach test revealed 1,609 (57.5%) CAS positive pts [male; n¼823 (51.1%), age;
55.0 (interquartile, 47.5-63.2)]. Baseline characteristics included hypertension [n¼ 663
(41.2%)], diabetes [n¼193 (11.9%)], dyslipidemia [n¼241 (14.9%)], current smokers
[n¼395 (24.5%)] and current alcoholics [n¼556 (34.5%)]. Ach provocation test
showed the incidence of myocardial bridge [n¼434 (26.9%)], baseline CAS [n¼ 495
(30.7%)], diffuse CAS [n¼1344 (83.5%)] and multi-vessel spasm [n¼555 (34.4%)].
After 3 years, recurrent chest pain [n¼102 (6.3%)] was the most common event. Other
events included all-cause death [n¼3 (0.1%)], cardiac death [n¼2 (0.1%)], myocardial
infarction [n¼3 (0.1%)], percutaneous coronary intervention [n¼3 (0.1%)] and cere-
brovascular accidents [n¼3 (0.1%)]. Multivariate analysis showed dyslipidemia (OR;
1.75, 95% C.I; 1.07-2.85, p¼0.025) and baseline CAS (OR; 1.91, 95% C.I; 1.26-2.88,
p¼0.002) to be strong independent predictors of recurrent chest pain (Table).
Conclusion: Dyslipidemia and baseline CAS were predictors of recurrent chest
pain in 3-year clinical outcomes. Therefore pts who have dyslipidemia or show
baseline CAS should receive intensive anti-anginal management and close clinical
follow up.
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The Role of Cardio-Ankle Vascular Index (CAVI) as an Indicator of the Severity of
Coronary Artery Disease - Virtual Histology Intravascular Ultrasound Analysis
Jee Eun Kwon, Sang-Wook Kim, Wang-Soo Lee, Joon Hwa Hong, Sharath Kumar,
Eun Young Kim, Kwang Je Lee, Chee Jeong Kim, Dai Yun Cho, Tae Ho Kim
Chung-Ang University Hospital, Seoul, Korea, Republic of
Background: Cardio-Ankle Vascular Index (CAVI) was developed as a parameter of
atherosclerosis that does not depend on the blood pressure than pulse wave velocity
(PWV). We assessed the predictive value of CAVI as an indicator of coronary artery
disease and whether it reﬂects the severity of CAD.
Method:We assessed CAVI in 474 patients before undergoing coronary angiography.
207 patients had normal coronary angiogram, and 267 patients were conﬁrmed to have
coronary artery disease. IVUS analysis of the culprit lesion was done. VH-IVUS-
deﬁned thin-capped ﬁbroatheroma (VH-TCFA) had necrotic core (NC) >10% of
plaque area, plaque burden >40%, and NC in contact with the lumen for 3 image
slices.
Results: CAVI was higher in patients with coronary artery disease than normal
patients (8.961.54 vs 8.031.39, p¼0.03). Among patient with coronary artery
disease, patients with multi-vessel disease showed higher value of CAVI
(8.761.53 vs 8.231.26, p¼0.001). IVUS analysis of the culprit lesion was
amenable in 102 pts who were divided into 2 groups: CAVI< 9(52pts) and
CAVI 9(50pts). While minimal lumen area, plaque burden and remodeling
index were similar, lesion length were longer in CAVI  9 group. CAVI showed
correlation with lesion length (r¼0.615, p<0.001), whereas not with minimal
lumen area (r¼-0.048, p¼0.672). Among 4 components (ﬁbrotic, ﬁbrofatty,
necrotic, calcium), lesion maximal calcium (%) was higher in CAVI  9 group
and also showed correlation with CAVI (r¼0.521, p<0.001). The frequency of
VH-TCFA phenotype was similar between the two groups (19/52 (36.5%) vs 17/
50(34%), p¼0.263).
Conclusions: High CAVI value might suggest more severe (longer lesion length) and
greater coronary artery disease complexity (more calciﬁed coronary plaque).CAVI < 9
(n¼52)CAVI  9
(n¼50) P valueLesion length (mm) 15.945.86 20.685.76 <0.001
Distal reference lumen
area (mm2)6.713.28 7.032.52 0.619MLA lumen area (mm2) 2.661.15 2.590.84 0.941
MLA plaque burden (%) 78.378.58 78.787.60 0.823
Remodeling index (MLA site) 0.840.18 0.780.16 0.117
Necrotic core (% ) (max. NC site) 33.879.41 32.839.09 0.614
Dense calcium (%) (max. NC site) 9.128.02 9.827.18 0.682
Lesion Max. dense calcium (%) 11.4810.43 18.7110.59 0.003CRT-155
Forced Diuresis with Matched Hydration Using the Renalguard

System for the
Prevention of Contrast Induced Acute Kidney Injury - A Single Center Experience
Eyal Ben-Assa, Yaron Arbel, Meital Rofe, Yacov Shacham, Maayan Konigstein,
Ofer Havakuk, Eran Leshem-Rubinow, Amir Halkin, Ariel Finkelstein, Gad Keren,
Shmuel Banai
Tel Aviv Medical Center, Tel Aviv, Israel
Background: Contrast-induced acute kidney injury (CI-AKI) is a frequent compli-
cation of coronary angiography associated with unfavorable outcome. Recently, two
randomized controlled trials have demonstrated that furosemide induced diuresis with
matched isotonic intravenous hydration using the RenalGuard system reduces the risk
of CI-AKI in high-risk patients undergoing coronary procedures. The efﬁcacy and
safety of this strategy has never been reported in real life practice.
Methods: We analyzed data of patients at high risk to develop CI-AKI who were
hospitalized in our cardiology department for acute coronary syndrome from August
2012 to September 2013 and were treated with the RenalGuard system during cor-
onary angiography with or without angioplasty. The AKI rate was compared to a novel
tool for accurate prediction of CI-AKI.
Results: 51 high risk patients were enrolled, 66% males, mean age of 74  9 years,
93% where hypertensive and 55% were diabetics. Mean ejection fraction was 4613%,
mean eGFR was 3713 ml/min/1.73m2 and mean baseline hemoglobin was 11.41.8
g/dL. The mean volume of contrast media delivered was 8434 ml (25 - 172). Ac-
cording to a novel prediction tool patients in this group had a calculated risk of 10.5%
for CI-AKI and 1.4% risk of requiring dialysis.
Forced dieresis was achieved with mean IV normal saline bolus of 26070 ml, and
mean IV furosemide of 5538 mg, achieving a mean urine rate of 443258 ml/hr at
the beginning of the procedure. Monitored by the RenalGuard system patients
received a mean IV hydration saline of 2209  1154 ml closely matched to mean urine
output of 24861173 ml, during a mean time of 5 hours and 45 minutes.
3 patients (5.8%) developed CI-AKI as deﬁned by >0.5 mg/dl or >25% rise in
serum creatinine at 48-72 h post contrast administration and non required dialysis. 2
Patients (3.9%) developed dyspnea during the treatment, and one patient (1.8%) had
peripheral venous catheter phlebitis. There was no urinary tract infection, no hypo-
kalemia and no hypernatremia in 48-72 hours following the procedure.
Conclusion: Forced diuresis with matched IV hydration is safe and reduces the risk of
CI-AKI in real world high risk patients.
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Percutaneous Treatment of Refractory Heart Failure Secondary to Old Myocardial
Infarction by Anteroapical Splinting Stent in the Left Anterior Descending Coronary
Hugo Gutiérrez Leonard, Luis Enrique Berumen Domínguez, José Luis Ojeda Delgado,
Rodolfo Barrios Nanni, Miguel Ramírez Aldaraca
Hospital Militar, Mexico, Mexico
Background: Determine the therapeutic effect of splinting with stenting the LAD.
Improve the NYHA functional class. Improve the ejection fraction.
Methods: A total of 48 patients between 62 and 74 years old, 31 men and 17 women,
from October 2009 through February 2013. We established a randomized study, 2
groups each one with 24 patients. All patients suffered refractory heart failure with left
fraction ejection less than 30% in class III and IV (NYHA classiﬁcation). Transthoracic
echocardiogram was performed at admission, 6 and 12 months, nuclear imagine was
done the day after improving their medical conditions, all studies shows no viability in
this territory and coronary angiography was done the next day. All patients suffered from
LAD disease only, and the vessel was patent in every one. We deliver bare metal stents
from distal to proximal, the stents used are from 2.5mm to 3.5mm in diameter and 28 to
36mm long. We performed coronary angiography and ventriculography by femoral ac-
cess then in themost severe lesions wemade angioplasty before delivering the stents as we
mentioned. All stents were spliced together with 5 mm each from distal to proximal just
to the main lesion. All patients are reassessed clinically each month and an echocardi-
ography study was performed at 6 and 12 months.
Results: The functional class improves in all the patients from the experimental group
(24 patients), 21 patients pass to II functional class and only 3 patients stayed in III
